Patents by Inventor Guenter Germann

Guenter Germann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200289715
    Abstract: A biocompatible soft tissue implant for introduction into a human body includes at least one layer comprising an elastomeric material, and at least one textile fabric arranged on the at least one layer comprising the elastomeric material. The at least one textile fabric forms a surface of the biocompatible soft tissue implant. The at least one textile fabric includes bioresorbable fibers which are embedded at least partially in the at least one layer comprising the elastomeric material.
    Type: Application
    Filed: October 26, 2018
    Publication date: September 17, 2020
    Inventors: Karl-Heinz Heffels, Denis Reibel, Dirk Grafahrend, Guenter Germann, Oliver Boegershausen
  • Publication number: 20200289716
    Abstract: A biocompatible composite material for complete or partial insertion into a human body includes at least one layer comprising an elastomeric material, and at least one textile fabric arranged on the at least one layer comprising the elastomeric material. The at least one textile fabric forms a surface of the biocompatible composite material. The at least one textile fabric includes bioresorbable fibers that are embedded at least partially in the at least one layer comprising the elastomeric material.
    Type: Application
    Filed: October 26, 2018
    Publication date: September 17, 2020
    Inventors: Karl-Heinz Heffels, Denis Reibel, Dirk Grafahrend, Alexandra Kaul, Yosuke Kadomae, Guenter Germann
  • Publication number: 20140234276
    Abstract: The present invention pertains to means and methods for the treatment of acute and chronic liver disease. In particular, it relates to a composition comprising human adipose stem cells for the prevention, amelioration or treatment of acute or chronic liver disease. Further encompassed by the invention is a kit comprising said composition and optionally means for isolating adipose stem cells and/or means for administering adipose stem cells.
    Type: Application
    Filed: August 6, 2012
    Publication date: August 21, 2014
    Applicants: HOPP STIFTUNG GMBH, ETHIANUM BETRIEBSGESELLSCHAFT MBH & CO.
    Inventors: Guenter Germann, Eva Koellensperger